Sort by
Refine Your Search
-
, establish cellular memory, and regulate plasticity. We leverage this knowledge to identify new epigenetic pathways for drug discovery. We use cutting-edge methods (multi-omics, single cell, live cell imaging
-
treatment. A large portion of all hospital patients suffer from multiple diseases and are already undergoing a complex drug therapy at the time of admission. For the most successful therapy, choice
-
inflammatory states, centred on a rational design of tailor-made nanoparticulate drug carriers. Pharmacologically active nanoparticles based on functional synthetic polymers and (modified) biopolymers will be
-
/ double degree programme No Description/content Our aim is to train a new generation of biomedical scientists who can take on the diverse challenges of making fundamental scientific discoveries in the basic
-
(MPI-C), the Max Planck Institute for Polymer Research (MPI-P), the Helmholtz Institute Mainz (HIM), the Institute of Biotechnology and Drug Research (IBWF), and the Institute of Molecular Biology (IMB